Your search returned 11 studies. (Get alerts for new studies):
- A Study to Compare Subcutaneous Versus Intravenous Administration of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Active Rheuma
Conditions: Rheumatoid Arthritis
Location: Olympia, Washington
- Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism
Conditions: Male Hypogonadism
Location: Olympia, Washington
- A Study of Two Doses of MRC375 in Moderate to Severe Rheumatoid Arthritis Patients With a 12 Week Open-label Extension
Conditions: Rheumatoid Arthritis
Location: Olympia, Washington
- Comparative Effectiveness Research Study of Peripheral Arterial Disease (PAD)
Conditions: Peripheral Arterial Disease - Claudication
Location: Aberdeen, Washington
- Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer
Conditions: Inflammatory Breast Cancer - Male Breast Cancer - Stage II Breast Cancer - Stage IIIA Breast Cancer - Stage IIIB Breast Cancer - Stage IIIC Breast Cancer
Location: Port Angeles, Washington
- A Study in Patients With Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2
Location: Olympia, Washington
- Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abn
Conditions: Primary Hypercholesterolemia - Mixed Dyslipidemia
Location: Olympia, Washington
- Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and Inhibitors
Conditions: Haemophilia A With Inhibitors - Haemophilia B With Inhibitors
Location: Olympia, Washington
- A Study of Ramucirumab in Patients With Gastric, Esophageal and Gastroesophageal Cancer
Conditions: Stomach Cancer - Esophageal Cancer
Location: Port Angeles, Washington
- A Study of LY2605541 in Participants With Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2
Location: Olympia, Washington
- Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773
Conditions: Haemophilia B
Location: Olympia, Washington
|